Popular Trials
Cancer Vaccine
RSV Vaccination + Immunization for Respiratory Syncytial Virus
Recruiting3 awardsPhase 4
Nashville, Tennessee
This trial is evaluating the effectiveness and longevity of antibodies against Respiratory Syncytial Virus (RSV) in infants up to 12 months old after receiving either a maternal RSV vaccine during pregnancy,
Behavioural Intervention
COACH for Childhood Obesity
Recruiting1 award3 criteria
Nashville, Tennessee
"This trial aims to improve access to evidence-based obesity treatment for children in underserved communities. They will adapt a community-based intervention called COACH to include individual, family, and community factors. The goal
Behavioural Intervention
Mindfulness Program for Reducing Negative Affect in Youth
Recruiting1 award1 criteria
Nashville, Tennessee
"This trial aims to see if an online mindfulness program can help reduce mood and anxiety symptoms in at-risk youth when compared to a support program and a no-intervention group. Adolescents aged 12 to
Popular Filters
Phase 3 Trials
Growth Hormone Receptor Agonist
Efruxifermin for Fatty Liver Disease
Recruiting1 awardPhase 3
Hermitage, Tennessee
"This trial will test the effectiveness of efruxifermin in treating liver cirrhosis caused by NASH/MASH in patients at multiple medical centers. It will be a randomized study where some participants
Trials With No Placebo
Procedure
Endoscopic vs Surgical Procedures for Gastric Outlet Obstruction
Recruiting1 award3 criteria
Nashville, Tennessee
This trial compares two procedures for treating a condition called malignant gastric outlet obstruction (GOO). The study found that EUS gastroenterostomy had better long-term results compared to enteral stents.
EGFR Tyrosine Kinase Inhibitor
STX-241 for Lung Cancer
Recruiting1 awardPhase 1 & 2
Nashville, Tennessee
This trial aims to test the safety, effectiveness, and recommended dosage of a new drug called STX-241 in patients with advanced lung cancer that has not responded to previous treatments. The drug is designed
Gene Therapy
Gene Therapy for Chronic Granulomatous Disease
Recruiting1 awardPhase 1 & 2
Nashville, Tennessee
This trial is testing a new gene therapy for people with a specific genetic disorder called Chronic Granulomatous Disease. The therapy involves modifying the patient's own stem cells outside the body and then transplanting
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.